SAN DIEGO, Aug. 30, 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, today announced the opening of its first manufacturing site in China. The new Shanghai-based facility enables localized production for Illumina’s gene sequencing instruments and consumables and reflects the growing demand in the Chinese market for Illumina’s systems and products.
Mizuho Maintains Buy on Universal Health Services, Lowers Price Target to $121
Mizuho analyst Ann Hynes maintains Universal Health Services (NYSE:UHS) with a Buy and lowers the price target from $153 to $121.
